Document Detail


Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
MedLine Citation:
PMID:  12711218     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Genetic analysis of hypertrophic cardiomyopathy (HCM), a mendelian form of cardiac hypertrophy, indicates that the primary defect is in sarcomeric function. However, the initial proposal that depressed myocardial contraction leads to a 'compensatory' hypertrophy has proven inconsistent with laboratory and clinical evidence. Drawing on observations of mutant contractile protein function, together with mouse models and clinical studies, we propose that sarcomeric HCM mutations lead to inefficient ATP utilization. The suggestion that energy depletion underlies HCM is supported by the HCM-like phenotype found with mutations in a variety of metabolic genes. A central role for compromised energetics would also help explain the unresolved clinical observations of delayed onset and asymmetrical hypertrophy in HCM, and would have implications for therapy in HCM and, potentially, in more-common forms of cardiac hypertrophy and failure.
Authors:
Houman Ashrafian; Charles Redwood; Edward Blair; Hugh Watkins
Related Documents :
6208988 - Regression of isoproterenol-induced cardiac hypertrophy.
2947748 - Alterations in the coronary circulation in hypertrophied ventricles.
2533528 - Importance of abnormalities in coronary flow reserve to the pathophysiology of left ven...
126048 - Apparent coexistent valvular and subvalvular left ventricular outflow tract obstruction.
3729068 - Vascular manifestations of systemic lupus erythematosus.
801308 - Immunofluorescent and migration inhibition studies in rats with experimental myocardial...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Trends in genetics : TIG     Volume:  19     ISSN:  0168-9525     ISO Abbreviation:  Trends Genet.     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-04-24     Completed Date:  2003-07-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8507085     Medline TA:  Trends Genet     Country:  England    
Other Details:
Languages:  eng     Pagination:  263-8     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine Triphosphate / metabolism
Cardiomyopathy, Hypertrophic / genetics*,  metabolism
Energy Metabolism*
Genetic Markers / genetics*
Humans
Mutation*
Myocardium / metabolism*
Chemical
Reg. No./Substance:
0/Genetic Markers; 56-65-5/Adenosine Triphosphate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interacti...
Next Document:  The methyl-CpG binding domain and the evolving role of DNA methylation in animals.